Ganglioside GM3 Participates in the Pathological Conditions of Insulin Resistance
Open accessThe DOI matches its Crossref record; 60 of the 62 references it cites were found in a registry or an index.
Abstract
Gangliosides are known as modulators of transmembrane signaling by regulating various receptor functions. We have found that insulin resistance induced by tumor necrosis factor-alpha (TNF-alpha) in 3T3-L1 adipocytes was accompanied by increased GM3 ganglioside expression caused by elevating GM3 synthase activity and its mRNA. We also demonstrated that TNF-alpha simultaneously produced insulin resistance by uncoupling insulin receptor activity toward insulin receptor substrate-1 (IRS-1) and suppressing insulin-sensitive glucose transport. Pharmacological depletion of GM3 in adipocytes by an inhibitor of glucosylceramide synthase prevented the TNF-alpha-induced defect in insulin-dependent tyrosine phosphorylation of IRS-1 and also counteracted the TNF-alpha-induced serine phosphorylation of IRS-1. Moreover, when the adipocytes were incubated with exogenous GM3, suppression of tyrosine phosphorylation of insulin receptor and IRS-1 and glucose uptake in response to insulin stimulation was observed, demonstrating that GM3 itself is able to mimic the effects of TNF on insulin signaling. We used the obese Zucker fa/fa rat and ob/ob mouse, which are known to overproduce TNF-alpha mRNA in adipose tissues, as typical models of insulin resistance. We found that the levels of GM3 synthase mRNA in adipose tissues of these animals were significantly higher than in their lean counterparts. Taken together, the increased synthesis of cellular GM3 by TNF may participate in the pathological conditions of insulin resistance in type 2 diabetes.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“and elimination of GM3 affects insulin receptor action (405, 523 -524).”
From Biological roles of glycans (2017) · cites this paper as [523]
Citations
Cites
Adipose Expression of Tumor Necrosis Factor-α: Direct Role in Obesity-Linked Insulin Resistance
Hotamisligil, G. S., Shargill, N. S., & Spiegelman, B. M. (1993) · Science · doi:10.1126/science.7678183 · Cited by 7,518
Heid, C. A., Stevens, J., Livak, K. J., & Williams, P. M. (1996) · Genome Research · doi:10.1101/gr.6.10.986 · Cited by 6,174
Hotamisligil, G. S., Arner, P., Caro, J. F., Atkinson, R. L., & Spiegelman, B. M. (1995) · Journal of Clinical Investigation · doi:10.1172/jci117936 · Cited by 3,543
Hotamisligil, G. S., Peraldi, P., Budavari, A., Ellis, R., White, M. F., & Spiegelman, B. M. (1996) · Science · doi:10.1126/science.271.5249.665 · Cited by 2,630
Protection from obesity-induced insulin resistance in mice lacking TNF-α function
Uysal, K. T., Wiesbrock, S. M., Marino, M. W., & Hotamisligil, G. S. (1997) · Nature · doi:10.1038/39335 · Cited by 2,234
Aguirre, V., Uchida, T., Yenush, L., Davis, R., & White, M. F. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.12.9047 · Cited by 1,487
Boyle, W. J., van der Geer, P., & Hunter, T. (1991) · Methods in Enzymology · doi:10.1016/0076-6879(91)01013-r · Cited by 1,434
Tumor Necrosis Factor α: A Key Component of the Obesity-Diabetes Link
Hotamisligil, G. S., & Spiegelman, B. M. (1994) · Diabetes · doi:10.2337/diab.43.11.1271 · Cited by 1,281
Tumor necrosis factor alpha inhibits signaling from the insulin receptor.
Hotamisligil, G. S., Murray, D. L., Choy, L. N., & Spiegelman, B. M. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.11.4854 · Cited by 1,199
Insulin Resistance — Mechanisms, Syndromes, and Implications
Epstein, F. H., Moller, D. E., & Flier, J. S. (1991) · New England Journal of Medicine · doi:10.1056/nejm199109263251307 · Cited by 801
Research works printed but not linked: 4
- Moller, 1992, N. Engl. J. Med., 325, 938
- Radin, 1993, Adv. Lipid Res., 26, 183
- Tanaka, 1994, 76, 374
- Engelman, 2000, Mol. Endocrinol., 14, 1557
Cited by
Items 201–300 of 357
Kasbi-Chadli, F., Ferchaud‐Roucher, V., Krempf, M., & Ouguerram, K. (2015) · European Journal of Nutrition · doi:10.1007/s00394-015-0879-0 · Cited by 26
“The glycosphingolipids, when highly concentrated, inhibit the phosphorylation of the insulin receptor, resulting in reduced response to insulin [47].”
BackgroundInamori, K., Ito, H., Tamura, Y., Nitta, T., Yang, X., Nihei, W., Shishido, F., Imazu, S., Tsukita, S., Yamada, T., et al. (2018) · Journal of Lipid Research · doi:10.1194/jlr.m085753 · Cited by 26
“5 g/ml leptin, washed twice with ice-cold PBS, lysed, and analyzed by Western blotting with appropriate antibodies, as described previously (2).”
BackgroundMethodSelf-citationMarijan, S., Markotić, A., Mastelić, A., Mužinić, N. R., Pilkington, L. I., Reynisson, J., & Čulić, V. Č. (2020) · Scientific Reports · doi:10.1038/s41598-020-68516-y · Cited by 23
An overview of therapeutic potential of N-alkylated 1-deoxynojirimycin congeners
Iftikhar, M., Lu, Y., & Zhou, M. (2021) · Carbohydrate Research · doi:10.1016/j.carres.2021.108317 · Cited by 22
The Role of Lipid Rafts in Trimeric G Protein-mediated Signal Transduction
Ohkubo, S., & Nakahata, N. (2007) · YAKUGAKU ZASSHI · doi:10.1248/yakushi.127.27 · Cited by 22
Carobbio, S., Pellegrinelli, V., & Vidal‐Puig, A. (2024) · Advances in experimental medicine and biology · doi:10.1007/978-3-031-63657-8_8 · Cited by 26
Yu, H., Gadi, M. R., Bai, Y., Zhang, L., Li, L., Yin, J., Wang, P. G., & Chen, X. (2021) · The Journal of Organic Chemistry · doi:10.1021/acs.joc.1c00450 · Cited by 21
Dietary Control of Ganglioside Expression in Mammalian Tissues
OKUDA, T. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms21010177 · Cited by 22
“GM3 EGF receptor [15] Insulin receptor [4,19,20]”
BackgroundObesity causes a shift in metabolic flow of gangliosides in adipose tissues
Tanabe, A., Matsuda, M., Fukuhara, A., Miyata, Y., Komuro, R., Shimomura, I., & Tojo, H. (2008) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2008.12.086 · Cited by 24
Hülsmeier, A. J. (2025) · Neurobiology of Disease · doi:10.1016/j.nbd.2025.106851 · Cited by 27
“In cultured adipocytes where insulin resistance has been induced by the inflammatory cytokine TNF α , inhibiting UGCG, the enzyme responsible for the first step in the biosynthesis of all GlcCer-derived GSLs, almost completely restores IR signaling (Tagami et al., 2002).”
Sphingolipid regulators of cellular dysfunction in Type 2 diabetes mellitus: a systems overview
Ross, J. S., Russo, S. B., Chavis, G. C., & Cowart, L. A. (2014) · Clinical Lipidology · doi:10.2217/clp.14.37 · Cited by 21
Sphingolipids as modulators of membrane proteins
Ernst, A. M., & Brügger, B. (2013) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2013.10.016 · Cited by 22
Uemura, S., Shishido, F., Kashimura, M., & Inokuchi, J. (2015) · Glycobiology · doi:10.1093/glycob/cwv071 · Cited by 21
Self-citationIlan, Y. (2009) · Clinical & Experimental Immunology · doi:10.1111/j.1365-2249.2009.04030.x · Cited by 24
Discovery and Characterization of an Inhibitor of Glucosylceramide Synthase
Richards, S. J., Larson, C. J., Koltun, E. S., Hanel, A., Chan, V., Nachtigall, J., Harrison, A., Aay, N., Du, H., Arcalas, A., et al. (2012) · Journal of Medicinal Chemistry · doi:10.1021/jm300122u · Cited by 25
Hoda, K., Ikeda, Y., Kawasaki, H., Yamada, K., Higuchi, R., & Shibata, O. (2006) · Colloids and Surfaces B Biointerfaces · doi:10.1016/j.colsurfb.2006.07.006 · Cited by 20
Inokuchi, J., & Kanoh, H. (2022) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2022.918346 · Cited by 21
“GM3 expression in adipocytes is induced by stimulation of the inflammatory cytokines TNF-α and IL-1β, derived from tissue macrophages (Tagami et al., 2002; Nagafuku et al., 2015).”
BackgroundSelf-citationPalmitate alters neuregulin signaling and biology in cardiac myocytes
Miller, T. A., Icli, B., Cote, G. M., LeBrasseur, N. K., Borkan, S. C., Pimentel, D. R., Peng, X., & Sawyer, D. B. (2008) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2008.11.150 · Cited by 23
Božić, J., Markotić, A., Čulić, V. Č., Novak, A., Borovac, J. A., Vučemilović, H., Trgo, G., & Kurir, T. T. (2017) · Journal of Diabetes · doi:10.1111/1753-0407.12569 · Cited by 22
“Over the long term, TNF-α promotes the transcription of GM3 synthase, subsequently leading to a higher GM3 content and attenuation of insulin signaling that is manifested through the suppression of glucose uptake.(16,17) Another important piece of the puzzle should be highlighted.”
BackgroundChiricozzi, E., Aureli, M., Mauri, L., Biase, E. D., Lunghi, G., Fazzari, M., Valsecchi, M., Carsana, E. V., Loberto, N., Prinetti, A., et al. (2021) · Advances in experimental medicine and biology · doi:10.1007/978-3-030-70115-4_3 · Cited by 20
Renal distribution of ganglioside GM3 in rat models of types 1 and 2 diabetes
Novak, A., Mužinić, N. R., Čulić, V. Č., Božić, J., Kurir, T. T., Ferhatović, L., Puljak, L., & Markotić, A. (2013) · Journal of Physiology and Biochemistry · doi:10.1007/s13105-013-0249-4 · Cited by 19
“It has been a widely reported important role of GM3 in cell growth regulation [40, 43], T cell activation [14], signal transduction [4], and insulin signaling [20, 21, 38].”
Gangliosides in Podocyte Biology and Disease
Savas, B., Astarita, G., Aureli, M., Sahali, D., & Ollero, M. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21249645 · Cited by 18
NEU3 sialidase as a marker of insulin sensitivity: Regulation by fatty acids
Lipina, C., Nardi, F., Grace, H., & Hundal, H. S. (2015) · Cellular Signalling · doi:10.1016/j.cellsig.2015.05.010 · Cited by 18
Vuković, I., Božić, J., Markotić, A., Ljubicic, S., & Kurir, T. T. (2015) · Kidney & Blood Pressure Research · doi:10.1159/000368506 · Cited by 22
Daniotti, J. L., Crespo, P. M., & Yamashita, T. (2006) · Journal of Cellular Biochemistry · doi:10.1002/jcb.21034 · Cited by 18
“Thus, it is known that EGF can cause different physiological responses of neural stem cells at different times of development [Tagami et al., 2002].”
BackgroundObanda, D. N., Yu, Y., Wang, Z. Q., & Cefalu, W. T. (2015) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2015.01.007 · Cited by 17
“It has been shown that inhibition of GM3 synthesis reverses TNF-α-induced insulin resistance in 3T3-L1 adipocytes andmice lacking the GM3 synthase gene display lower fasting glucose levels and improved glucose tolerance [20,21].”
BackgroundBijl, N., Scheij, S. S., Houten, S. M., Boot, R. G., Groen, A. K., & Aerts, J. M. F. G. (2008) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.108.139394 · Cited by 19
“Furthermore, addition of GM3 to adipocytes in culture suppresses phosphorylation of the insulin receptor, resulting in reduced glucose uptake (Tagami et al., 2002).”
BackgroundGene Regulation Using Spherical Nucleic Acids to Treat Skin Disorders
Holmes, T. R., & Paller, A. S. (2020) · Pharmaceuticals · doi:10.3390/ph13110360 · Cited by 19
“Nearly 10% of all Americans are diagnosed with T2D or pre-T2D, and 25% of these individuals will develop a foot ulcer in their lifetime.”
BackgroundInfluentialGanglioside GM3 Synthase Deficiency in Mouse Models and Human Patients
Inamori, K., & Inokuchi, J. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23105368 · Cited by 18
“Our group observed elevated GM3 expression in adipose tissues of obese model Zucker fa/fa rats and ob/ob mice, and of HFD-induced obese wild-type (WT) C57BL/6 mice, which have upregulated TNF-α expression in adipose tissues and develop insulin resistance [12,33].”
BackgroundSelf-citationKamani, M., Mylvaganam, M., Tian, R., Rigat, B. A., Binnington, B., & Lingwood, C. A. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.207670 · Cited by 18
Mastelić, A., Čulić, V. Č., Mužinić, N. R., Vuica‐Ross, M., Barker, D. L. A., Leung, E. Y., Reynisson, J., & Markotić, A. (2017) · Drug Design Development and Therapy · doi:10.2147/dddt.s121122 · Cited by 16
“In the case of insulin resistance, enhanced GM3 lipid raft content disturbs insulin receptor function.(15) In our study, the change in number of GM3 molecules per one cell after the drug treatment, expressed as GM3 geometric mean fluorescence intensity (GMI), would indicate the possible involvement of disturbed GM3 li…”
BackgroundLunghi, G., Fazzari, M., Ciampa, M. G., Mauri, L., Biase, E. D., Chiricozzi, E., & Sonnino, S. (2022) · FEBS Letters · doi:10.1002/1873-3468.14532 · Cited by 17
Roles of Gangliosides in Hypothalamic Control of Energy Balance: New Insights
Inamori, K., & Inokuchi, J. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21155349 · Cited by 15
“GM3 synthase (GM3S, encoded by St3gal5) is a sialyltransferase that transfers sialic acid residue to LacCer via α2,3-linkage to form GM3 ganglioside.”
BackgroundSelf-citationDiscovery of a new class of glucosylceramide synthase inhibitors
Koltun, E. S., Richards, S. J., Chan, V., Nachtigall, J., Du, H., Noson, K. D., Galan, A. A., Aay, N., Hanel, A., Harrison, A., et al. (2011) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2011.09.037 · Cited by 14
Furukawa, K., Tajima, O., OKUDA, T., Tokuda, N., & Furukawa, K. (2007) · Elsevier eBooks · doi:10.1016/b978-044451967-2/00086-6 · Cited by 19
GD1b-Derived Gangliosides Modulate FcεRI Endocytosis in Mast Cells
Mazucato, V. M., Souza, A. M. M. S. E., Nicoletti, L. M., Jamur, M. C., & Oliver, C. (2011) · Journal of Histochemistry & Cytochemistry · doi:10.1369/0022155411400868 · Cited by 16
“GM3 inhibits signaling through the epidermal growth factor receptor (EGFR) by preventing dimerization of the receptor and its autophosphorylation (Rebbaa et al. 1996).”
BackgroundMurozuka, Y., Watanabe, N., Hatanaka, K., & Hakomori, S. (2007) · Glycoconjugate Journal · doi:10.1007/s10719-007-9051-2 · Cited by 15
Emerging Roles for Sphingolipids in Cardiometabolic Disease: A Rational Therapeutic Target?
Foran, D., Antoniades, C. A., & Akoumianakis, I. (2024) · Nutrients · doi:10.3390/nu16193296 · Cited by 17
“One particular complex glycosphingolipid, GM3, has been shown through cell and animal studies to be an especially potent inhibitor of insulin signalling [223].”
BackgroundBerkowitz, L., Razquín, C., Salazar, C., Biancardi, F., Estruch, R., Ros, E., Fitó, M., Corella, D., Coe, C. L., Ryff, C. D., et al. (2024) · Cardiovascular Diabetology · doi:10.1186/s12933-024-02505-7 · Cited by 18
“Similarly, it could also result from increased turnover for enhanced GM3 formation, another glycosphingolipid associated with diabetes [39].”
Roy, P., Saha, S., & Chakraborty, J. (2021) · Journal of Drug Delivery Science and Technology · doi:10.1016/j.jddst.2021.102830 · Cited by 14
Characterization and Roles of Membrane Lipids in Fatty Liver Disease
Welch, M., Secunda, C., Ghimire, N., Martinez, I., Mathus, A., Patel, U., Bhogoju, S., Al‐Mutairi, M., Min, K., & Lawan, A. (2022) · Membranes · doi:10.3390/membranes12040410 · Cited by 18
“GM3 accumulation was detected in lipid rafts by TNF-α stimulation [34,35].”
BackgroundSynthesis and Evaluation of Hybrid Structures Composed of Two Glucosylceramide Synthase Inhibitors
van den Berg, R. J. B. H. N., van Rijssel, E. R., Ferraz, M. J., Houben-Weerts, J. H. P. M., Strijland, A., Donker‐Koopman, W. E., Wennekes, T., Bonger, K. M., Ghisaidoobe, A. B. T., Hoogendoorn, S., et al. (2015) · ChemMedChem · doi:10.1002/cmdc.201500407 · Cited by 14
Investigating the pathogenesis and risk of Type 2 diabetes: clinical applications of metabolomics
Ng, T. W., Khan, A. A., & Meikle, P. J. (2012) · Clinical Lipidology · doi:10.2217/clp.12.75 · Cited by 14
Noël, A., Ingrand, S. S., & Barrier, L. (2016) · Molecular and Cellular Neuroscience · doi:10.1016/j.mcn.2016.06.009 · Cited by 15
The Physiological Importance of Bile Acid Structure and Composition on Glucose Homeostasis
Higuchi, S. (2020) · Current Diabetes Reports · doi:10.1007/s11892-020-01329-5 · Cited by 13
Gangliosides modulate insulin secretion by pancreatic beta cells under glucose stress
Jennemann, R., Kaden, S., Volz, M., Nordström, V., Herzer, S., Sandhoff, R., & Gröne, H. (2020) · Glycobiology · doi:10.1093/glycob/cwaa022 · Cited by 15
The impact of the glycan headgroup on the nanoscopic segregation of gangliosides
Sarmento, M. J., Owen, M. C., Ricardo, J. C., Chmelová, B., Davidović, D., Mikhalyov, I. I., Gretskaya, N. M., Hof, M., Amaro, M., Vácha, R., et al. (2021) · Biophysical Journal · doi:10.1016/j.bpj.2021.11.017 · Cited by 12
Dissecting PUGNAc-mediated inhibition of the pro-survival action of insulin
Teo, C. F., Elkarim, E. A., & Wells, L. (2016) · Glycobiology · doi:10.1093/glycob/cww043 · Cited by 13
“For example, using a cytokineinduced insulin resistant adipocyte model, Inokuchi and colleagues detected an upregulation in GM3 synthase expression, an accumulation in GM3 levels and a disruption in insulin-mediated signal transmission (Kabayama et al. 2005; Tagami et al. 2002).”
MethodSphingolipids in adipose tissue: What's tipping the scale?
Lambert, J. M., Anderson, A. K., & Cowart, L. A. (2018) · Advances in Biological Regulation · doi:10.1016/j.jbior.2018.10.002 · Cited by 13
Iioka, H., Saito, K., & Kondo, E. (2019) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2019.08.161 · Cited by 12
Svirin, E. P., de Munter, J., Umriukhin, A., Sheveleva, E., Kalueff, A. V., Svistunov, A. A., Morozov, S., Walitza, S., & Strekalova, T. V. (2022) · Biomolecules · doi:10.3390/biom12101434 · Cited by 13
“Ganglioside GM3 was shown to regulate IR activation in membrane microdomains by suppressing its phosphorylation [9] and may mediate the inhibitory effects of TNF on the IR [81].”
BackgroundWan, L.-Y., Lam, S. M., Huang, H.-H., Cao, W., Cao, X.-Y., Li, X., Zhang, L., Gao, J., Zhang, C., Fan, X., et al. (2025) · Journal of Translational Medicine · doi:10.1186/s12967-025-06168-0 · Cited by 15
“In addition, GM3 had been shown to be induced by TNF treatment in cultured adipocytes [40].”
Ji, Q., Gao, L., Liu, H., Chen, X., Fu, B., Lin, Y., & Wang, F. (2025) · Frontiers in Endocrinology · doi:10.3389/fendo.2025.1687146 · Cited by 17
Hepatic Topology of Glycosphingolipids in Schistosoma mansoni-Infected Hamsters
Luh, D., Heiles, S., Roderfeld, M., Grevelding, C. G., Roeb, E., & Spengler, B. (2024) · Analytical Chemistry · doi:10.1021/acs.analchem.3c05846 · Cited by 14
OKUDA, T., & Morita, N. (2015) · Journal of Functional Foods · doi:10.1016/j.jff.2015.11.040 · Cited by 11
Strekalova, T. V., Veniaminova, E. A., Svirin, E. P., Kopeikina, E., Veremeyko, T., Yung, A. W. Y., Proshin, A. T., Tan, S. Z. K., Khairuddin, S., Lim, L. W., et al. (2021) · Biomolecules · doi:10.3390/biom11121759 · Cited by 12
Ikeda, Y., Inagaki, M., Yamada, K., Miyamoto, T., Higuchi, R., & Shibata, O. (2009) · Colloids and Surfaces B Biointerfaces · doi:10.1016/j.colsurfb.2009.04.015 · Cited by 11
Sonnino, S., Chigorno, V., Aureli, M., Masilamani, A. P., Valsecchi, M., Loberto, N., Prioni, S., Mauri, L., & Prinetti, A. (2011) · Advances in experimental medicine and biology · doi:10.1007/978-1-4419-7877-6_14 · Cited by 13
Regulation of triglyceride metabolism in medaka (Oryzias latipes) hepatocytes by Neu3a sialidase
Oishi, K., Miyazaki, M., Takase, R., Chigwechokha, P. K., Komatsu, M., & Shiozaki, K. (2019) · Fish Physiology and Biochemistry · doi:10.1007/s10695-019-00730-6 · Cited by 11
Obanda, D. N., Ribnicky, D., Raskin, I., & Cefalu, W. T. (2014) · Nutrition · doi:10.1016/j.nut.2014.03.006 · Cited by 12
“The transfer of glucose from UDP-glucose to ceramide by GCS is the first step in glycosphingolipid synthesis [17, 18].”
BackgroundBedia, C., Badia-Villanueva, M., Muixí, L., Levade, T., Tauler, R., & Sierra, À. (2019) · Scientific Reports · doi:10.1038/s41598-019-50761-5 · Cited by 11
Synthesis of ganglioside Hp-s1
Chen, W., Sawant, R. C., Yang, S., Liao, Y.-J., Liao, J., Badsara, S. S., & Luo, S. (2014) · RSC Advances · doi:10.1039/c4ra08272a · Cited by 10
Sasaki, N., Itakura, Y., & Toyoda, M. (2017) · Oncotarget · doi:10.18632/oncotarget.23726 · Cited by 10
“In 3T3-L1 adipocytes, increased levels of monosialodihexosylganglioside (GM3) upon TNFα stimulation were found to contribute to insulin resistance in pathological conditions such as obesity [24].”
BackgroundST3 Beta-Galactoside Alpha-2,3-Sialyltransferase 5 (ST3GAL5)
Inokuchi, J., & Uemura, S. (2014) · Springer eBooks · doi:10.1007/978-4-431-54240-7_61 · Cited by 10
Self-citationTajima, O., Fujita, Y., Ohmi, Y., Furukawa, K., & Furukawa, K. (2023) · PLoS ONE · doi:10.1371/journal.pone.0281414 · Cited by 10
“It was reported that increased synthesis of cellular GM3 might be involved in tumor necrosis factor-α (TNFα)-induced insulin resistance in cultured adipocytes [16].”
BackgroundEliglustat tartrate, a prototypic glucosylceramide synthase inhibitor
Shayman, J. A. (2013) · Expert Review of Endocrinology & Metabolism · doi:10.1586/17446651.2013.846213 · Cited by 10
Modulation of Growth Factor Receptors in Membrane Microdomains
Inokuchi, J., & Kabayama, K. (2008) · Trends in Glycoscience and Glycotechnology · doi:10.4052/tigg.20.353 · Cited by 11
Self-citationThe factors affecting lipid profile in adult patients with Mucopolysaccharidosis
Stępień, K. M., Stewart, F. J., & Hendriksz, C. J. (2017) · Molecular Genetics and Metabolism Reports · doi:10.1016/j.ymgmr.2017.05.006 · Cited by 11
“In contrast, increased GM3 ganglioside levels impair insulin receptor signalling [49].”
BackgroundMaruta, T., Hoda, K., Inagaki, M., Higuchi, R., & Shibata, O. (2005) · Colloids and Surfaces B Biointerfaces · doi:10.1016/j.colsurfb.2005.06.006 · Cited by 9
Suteanu‐Simulescu, A., Sârbu, M., Ică, R., Petrică, L., & Zamfir, A. D. (2022) · Electrophoresis · doi:10.1002/elps.202200229 · Cited by 8
“Conceivably, from the clinical point of view, defects in the regular ganglioside profile can cause the development of a variety of diseases, including lysosomal storage diseases caused by defects in the lysosomal glycosidases (GM1 gangliosidosis—Tay–Sachs, GM2 gangliosidosis— Sandhoff), Gaucher [26], neurodegenerative…”
BackgroundMatsumoto, K., Sato, T., Oka, S., Orba, Y., Sawa, H., Kabayama, K., Inokuchi, J., & Ariga, H. (2004) · Genes to Cells · doi:10.1111/j.1356-9597.2004.00755.x · Cited by 10
Self-citationKundu, S., Rohokale, R., Lin, C., Chen, S., Biswas, S., & Guo, Z. (2024) · Journal of Lipid Research · doi:10.1016/j.jlr.2024.100570 · Cited by 7
“As a result, many proteins, such as Galectin (39), death receptor Fas (40), notch ligand delta-like 1 protein (41), Serotonin (42), insulin receptors (43), and numerous growth factor receptors (44 – 52), have been found to interact with GSLs.”
Mitrofanova, A. V., Fontanella, A. M., Molina, J., Zhang, G., Mallela, S. K., Severino, L. U., Javier Varona Santos, J., Tolerico, M., Njeim, R., Issa, W., et al. (2025) · Kidney International · doi:10.1016/j.kint.2025.04.024 · Cited by 10
“In DKD, glycosphingolipids were shown to cause insulin resistance, whereby the ganglioside GM3 interacts with insulin receptor causing its sequestration from cholesterol-enriched rafts 65,66 and insulin signaling deficiency.”
Inhibition of Ganglioside Biosynthesis as a Novel Therapeutic Approach in Insulin Resistance
Inokuchi, J. (2011) · Handbook of experimental pharmacology · doi:10.1007/978-3-642-17214-4_8 · Cited by 7
“This was reflected by increases in cellular GM3 content,GM3 synthase activity, and GM3 synthase mRNA content, indicating that TNFa upregulates GM3 synthesis at the transcriptional level in cultured adipocytes (Tagami et al. 2002).”
BackgroundSelf-citationGlycosyltransferase B4GALNT1 and type 1 diabetes in Croatian population
Perica, V. B., Torlak, V., Škrabić, V., Kačić, Z., Jakšić, J., Stipančić, G., Uroić, A. Š., Markotić, A., & Zemunik, T. (2009) · Clinical Biochemistry · doi:10.1016/j.clinbiochem.2009.01.012 · Cited by 7
Contribution Of Sphingolipids To The Pathogenesis Of Obesity
Samad, F. (2007) · Future Lipidology · doi:10.2217/17460875.2.6.625 · Cited by 8
van Eijk, M., Aten, J., Bijl, N., Ottenhoff, R., van Roomen, C. P. A. A., Dubbelhuis, P. F., Seemann, I., der Vlugt, K. G., Overkleeft, H. S., ARBEENY, C. M., et al. (2009) · Chemistry and Physics of Lipids · doi:10.1016/j.chemphyslip.2009.06.130 · Cited by 7
Receptor Modifications in Glycobiology
Inokuchi, J., & Kabayama, K. (2007) · Elsevier eBooks · doi:10.1016/b978-044451967-2/00071-4 · Cited by 8
Self-citationUrinary sphingolipids in adolescents and young adults with youth-onset diabetes
Nehus, E. J., SHEANON, N. M., Zhang, W., Marcovina, S. M., Setchell, K. D. R., & Mitsnefes, M. M. (2024) · Pediatric Nephrology · doi:10.1007/s00467-023-06257-6 · Cited by 6
“For example, GM3 ganglioside, a higher order glycosphin-golipid, antagonizes insulin resistance and is increased in the kidney tissue of rats with type 1 diabetes [40, 41].”
Assay Development and Screening for the Identification of Ganglioside GM3 Synthase Inhibitors
Yamanaka, K., Takahashi, Y., Azuma, Y., & Hantani, Y. (2020) · Biochemistry · doi:10.1021/acs.biochem.0c00055 · Cited by 6
Cheval, L., Poindessous, V., Sampaio, J. L., Crambert, G., & Pallet, N. (2024) · Function · doi:10.1093/function/zqae016 · Cited by 5
“31 , 32 , 35 F inally, w e observ ed high expr ession of SM in PCT and com-parati v el y lower expression in CTAL and CCD ( Figure 4 C).”
BackgroundResultAnchored and soluble gangliosides contribute to myelosupportivity of stromal cells
Ziulkoski, A. L., Santos, A. X. S., Andrade, C. M. B., Trindade, V. M. T., Daniotti, J. L., Borojević, R., & Guma, F. T. C. R. (2009) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2009.07.092 · Cited by 5
Langeveld, M., van den Berg, S. A. A., Bijl, N., Bijland, S., van Roomen, C. P. A. A., Houben-Weerts, J. H. P. M., Ottenhoff, R., Houten, S. M., van Dijk, K. W., Romijn, J. A., et al. (2011) · Metabolism · doi:10.1016/j.metabol.2011.05.013 · Cited by 6
“[20] Tagami S, Inokuchi JJ, Kabayama K, et al.”
BackgroundMeter, D., Racetin, A., Vukojević, K., Balog, M., Ivić, V., Zjalić, M., Heffer, M., & Filipović, N. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23116237 · Cited by 9
Noël, A., Ingrand, S. S., & Barrier, L. (2015) · Experimental Neurology · doi:10.1016/j.expneurol.2015.06.021 · Cited by 5
Interactions Between Caveolin-1 and Sphingolipids, and Their Functional Relevance
Sonnino, S., Prioni, S., Chigorno, V., & Prinetti, A. (2012) · Advances in experimental medicine and biology · doi:10.1007/978-1-4614-3381-1_8 · Cited by 5
Sun, C. Q., Hubl, U., Hoefakker, P., Vasudevamurthy, M. K., & Johnson, K. D. (2014) · PLoS ONE · doi:10.1371/journal.pone.0094206 · Cited by 4
“In adult life, studies have shown that gangliosides are important in the health of the neurological system [11,12] as well as insulin signalling [13,14].”
BackgroundHong, K., Jeong, S. W., Chung, M., & Cho, S. B. (2014) · PLoS ONE · doi:10.1371/journal.pone.0114128 · Cited by 4
“Although B3GALT4 mitigates ganglioside activity in neurodegenerative disorders, such as Huntington disease [29], it was also reported that gangliosides are related to the immunological pathophysiology of type 1 diabetes and to insulin resistance in type 2 diabetes [30, 31].”
BackgroundDyleva, Y. A., Gruzdeva, O. V., & Belik, E. V. (2020) · Obesity and metabolism · doi:10.14341/omet12565 · Cited by 6
Disruption of morphogenic and growth pathways in lysosomal storage diseases
Corrêa, T., Feltes, B. C., Giugliani, R., & Matte, Ú. D. S. (2021) · WIREs Mechanisms of Disease · doi:10.1002/wsbm.1521 · Cited by 4
Interorgan Metabolism of Ganglioside Is Altered in Type 2 Diabetes
Rivas‐Serna, I. M., Beveridge, M., Wilke, M. S., Ryan, E. A., Clandinin, M. T., & Mazurak, V. C. (2022) · Biomedicines · doi:10.3390/biomedicines10123141 · Cited by 4
“TNF-α activates GM3 synthase gene in 3T3-L1 adipocytes and the addition of exogenous GM3 inhibits the phosphorylation of insulin receptor [32].”
BackgroundVisual Function in Mice Lacking GM3 Synthase
Hiraoka, M., Ohkawa, E., Abe, A., Murata, M., Go, S., Inokuchi, J., & Ohguro, H. (2019) · Current Eye Research · doi:10.1080/02713683.2019.1576206 · Cited by 6
Self-citationInteraction of the GM2 Activator Protein with Sulfated and Sialylated Glycosphingolipids
Hepbildikler, S. T., Wendeler, M., Sandhoff, R., & Sandhoff, K. (2003) · Methods in enzymology on CD-ROM/Methods in enzymology · doi:10.1016/s0076-6879(03)01053-x · Cited by 4
Ganglioside deficiency in hypothalamic POMC neurons promotes body weight gain
Dieterle, V., Herzer, S., Gröne, H., Jennemann, R., & Nordström, V. (2019) · International Journal of Obesity · doi:10.1038/s41366-019-0388-y · Cited by 4
Shishido, F., Uemura, S., Kashimura, M., & Inokuchi, J. (2017) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/j.bbamem.2017.07.006 · Cited by 5
Self-citationGangliosides in T cell development and function of mice
Inokuchi, J., & Nagafuku, M. (2022) · Glycoconjugate Journal · doi:10.1007/s10719-021-10037-5 · Cited by 3
Self-citationCéramides, acteurs cruciaux dans le développement de l’insulino-résistance et du diabète de type 2
Tan, S., Bourron, O., & Hajduch, É. (2020) · médecine/sciences · doi:10.1051/medsci/2020091 · Cited by 9
Autophagy, the “Master” Regulator of Cellular Quality Control: What Happens when Autophagy Fails?
Raquel, A., Catarina, R. A., & Morais, S. (2013) · InTech eBooks · doi:10.5772/55196 · Cited by 4
“As palmitate is the precursor of ceramide and sphingolipid biosynthesis, the sphingolipid pathway has been implicated in the etiology of insulin resistance [168].”
BackgroundIshii, T., Miyauchi, K., Nitta, Y., Kaneko, K., Maruyama, T., & SATO, T. A. (2018) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.b18-00360 · Cited by 3
Impaired Wound Healing in Diabetic Ulcers: Accelerated Healing Through Depletion of Ganglioside
Dam, D. H. M., Jelsma, S. A., & Paller, A. S. (2017) · Wiley eBooks · doi:10.1002/9781119282518.ch13 · Cited by 3
Metadata
- Authors
- Tagami, S., Inokuchi, J.-I., Kabayama, K., Yoshimura, H., Kitamura, F., Uemura, S., Ogawa, C., Ishii, A., Saito, M., Ohtsuka, Y., Sakaue, S., & Igarashi, Y.
- Affiliations
- Hokkaido University (JP)
- National Cancer Centre Japan (JP)
- Corresponding author
- Inokuchi, Jin-ichi
- ORCID
- Venue
- Journal of Biological Chemistry
- Publisher
- Elsevier BV
- Published
- 2002-02
- Volume
- 277
- Issue
- 5
- Pages
- 3085-3092
- ISSN
- 0021-9258 (ISSN-L)
- OpenAlex
- W2157934599
- Cited by
- 355
- References
- 62
- Citations by year
- 2026: 4 · 2025: 6 · 2024: 10 · 2023: 2 · 2022: 16 · 2021: 14 · 2020: 27 · 2019: 14 · 2018: 13 · 2017: 13 · 2016: 14 · 2015: 23 · 2014: 17 · 2013: 18 · 2012: 19
- FWCI
- 8.36
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- cc-by
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- creativecommons.org/licenses/by/4.0/ (vor, 6818 d)
- Locations
- Journal of Biological Chemistry (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adipokines, Inflammation, and Metabolic Diseases
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Sphingolipid Metabolism and Signaling
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Lipid metabolism and biosynthesis
- Keywords
- GM3 ganglioside, insulin resistance, TNF-α, GM3 synthase, IRS-1, IRS-1 serine phosphorylation, insulin receptor tyrosine phosphorylation, glucose transport, adipocytes, type 2 diabetes, obesity, glucosylceramide synthase inhibition, 3T3-L1 adipocytes, Zucker fatty rats, ob/ob mice
- MeSH terms
- Animals, Cell Differentiation, Enzyme Inhibitors, G(M3) Ganglioside, Glucosyltransferases, Insulin, Insulin Resistance, Mice, Obese, Rats, Zucker, Sialyltransferases, Transcription, Genetic, Tumor Necrosis Factor-alpha, Signal Transduction, 3T3 Cells, Adipocytes, Mice, Rats
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.